NEW YORK, February 18 - Takeda has extended its subscription to Gene Logic's GeneExpress database and tools, Gene Logic said today.
The agreement expands Takeda's access to Gene Logic's BioExpress dataset, which it accesses along with the company's ToxExpress system and its GeneExpress expression database under a multi-year agreement it signed last March.
Financial terms of the deal, completed in collaboration with Amersham Biosciences KK, Gene Logic's sales and marketing partner in
BioExpress includes genomic and clinical data derived from a variety of normal and diseased human tissues, tissues from model animal systems, and human and animal cell lines. ToxExpress is a database containing expression profiles from organs affected by toxicity and the results of rat and human cell samples treated with various compounds. Gene Logic claims ToxExpress can predict what compounds may cause liver toxicity. GeneExpress was designed to help researchers mine, analyze, index, and visualize data.
Takeda, a Japanese drug and vitamin powerhouse, has annual sales topping $7 billion.